Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Market Outlook (2025–2034)

The global Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) market was valued at USD 21.70 billion in 2024 and is projected to grow at a CAGR of 5.40% during the forecast period 2025–2034, reaching around USD 34.84 billion by 2034. This growth is fueled by a rising shift away from opioid analgesics and increased patient awareness regarding the side effects and benefits of NSAID use in pain management and inflammation control across various therapeutic areas.